Pathology Grand Rounds, Ruth A. Keri, Ph.D., Mechanism-based Therapeutic Discovery in Breast Cancer
Tuesday, May 15, 2018 Noon - 1:00 pm
At the conclusion of this activity, the participant will be able to:
1. Attendees will be able to discriminate between subtypes of breast cancer and the importance of these subtypes in treating disease.
2. Attendees will be able to explain the limitations of mTOR inhibition for cancer therapy and approaches used to overcome those limitations.
3. Attendees will be able to describe the mechanisms of action of the epigenetic BET inhibitors in triple negative breast cancer.
.png)
- Sponsor(s)
- Medicine: Pathology
- Speaker(s)
- Ruth A. Keri, Ph.D. Professor and Vice Chair, Department of Pharmacology Associate Director for Basic Research, Case Comprehensive Cancer Center, School of Medicine, Case Western Reserve University
- Audience
- All ( Open to the public )